Gerhard Scherer

Prof. Dr. Gerhard Scherer

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
GSGerhard Scherer
Gerhard Scherer
JEJohannes Engl
Johannes Engl
MUMichael Urban
Michael Urban
GGGerhard Gilch
Gerhard Gilch
DJDinamis Janket
Dinamis Janket
KRKirsten Riedel
Kirsten Riedel

1 April 2006 in Journal of Analytical Toxicology
Verified
Journal Article
Open access
PDF file
KRKirsten Riedel
Kirsten Riedel
GSGerhard Scherer
Gerhard Scherer
JEJohannes Engl
Johannes Engl
HHHeinz-Werner Hagedorn
Heinz-Werner Hagedorn
ATAnthony R. Tricker
Anthony R. Tricker
Aromatic amines (arylamines) such as o-toluidine, 2-aminonaphthalene, and 4-aminobiphenyl occur in the environment and are constituents of tobacco smoke. Human exposure to these aromatic amines has long been associated with an elevated risk of bladder cancer. A validated, specific, and sensitive method for measuring o-toluidine, 2-aminonaphthalene, and 4-aminobiphenyl in cigarette smokers and nonsmokers was developed. The method uses acid hydrolysis of the arylamine conjugates in urine, extraction with n-hexane, derivatization with pentafluoropropionic anhydride, and subsequent analysis with gas chromatography combined with mass spectrometry using negative ion chemical ionization. The limits of detection were 4 ng/L for o-toluidine and 1 ng/L for 2-aminonaphthalene and 4-aminobiphenyl. Smokers (N = 10) excreted significantly higher amounts of o-toluidine (204 versus 104 ng/24 h), 2-aminonaphthalene (20.8 versus 10.7 ng/24 h), and 4-aminobiphenyl (15.3 versus 9.6 ng/24 h) than nonsmokers (N = 10). Urinary arylamine excretion in smokers was associated with the extent of smoking as assessed by daily cigarette consumption, urinary excretion of nicotine equivalents (nicotine plus its five major metabolites), cotinine in saliva, and carbon monoxide in exhaled breath. All nonsmokers investigated had quantifiable amounts of o-toluidine, 2-aminonaphthalene, and 4-aminobiphenyl in their urine, confirming that other environmental sources of exposure to these compounds also occur. In conclusion, the analytical method is suitable for measuring short-term exposure to arylamines in urine of non-occupationally exposed smokers and nonsmokers.

1 November 2006 in Experimental and Toxicologic Pathology
Verified
Journal Article
Closed access
GSGerhard Scherer
Gerhard Scherer

3 November 2010 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
BRBernhard Ramsauer
Bernhard Ramsauer
KSKatharina Sterz
Katharina Sterz
HHHeinz-Werner Hagedorn
Heinz-Werner Hagedorn
JEJohannes Engl
Johannes Engl
GSGerhard Scherer
Gerhard Scherer
FCFrancis Cheung
Francis Cheung

1 December 2014 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
GSGerhard Scherer
Gerhard Scherer
PLPeter Lee
Peter Lee

1 July 2005 in Experimental and Toxicologic Pathology
Verified
Journal Article
Closed access
GSGerhard Scherer
Gerhard Scherer